Aktuelle News
News Funktionen
Weitere Funktionen
27 April 2018
Therma Bright Inc.
Therma Bright Announces 1st Tranche Financing for $550,000 Through an Equity Private Placement and Convertible Debenture Offering
19 April 2018
Therma Bright Inc.
Therma Bright Announces: Further Testing of TherOZap(TM) Technology at Inhibiting Zika and Other Mosquito Borne Diseases, Proposed Financings and Acquisition Update
3 April 2018
Therma Bright Inc.
Therma Bright to Amend Definitive Agreement to Acquire ClearTouch(R) Nail Phototherapy Device and no!no! skin(R) Phototherapy Acne Device
14 März 2018
Therma Bright Inc.
Therma Bright Signs Definitive Agreement to Acquire ClearTouch(R) Nail Phototherapy Device and no!no! skin(R) Phototherapy Acne Device
2 März 2018
Therma Bright Inc.
Therma Bright Finalizes Terms on Acquisition, Adds Advisory Board Member and Grants Options
7 Februar 2018
Therma Bright Inc.
Jenex Announces Continuation to BC and Name Change to ‘Therma Bright Inc.’
1 Februar 2018
Therma Bright Inc.
Jenex Announces Non-Binding Letter of Intent with Quinsam Capital Corp. for $250,000 Investment to Develop CBD and THC Related Thermal Therapy Technology for Pain Relief and Other Pain Related Applications
30 Januar 2018
Therma Bright Inc.
Jenex Completes Due Diligence on Acquisition Targets
17 Januar 2018
Therma Bright Inc.
The Jenex Corporation Announces Board Change; Appointment of Advisory Board, Debt Settlement and Option Grants
8 Januar 2018
Therma Bright Inc.
Jenex’s TherOZap(TM) Technology Indicates Effectiveness in Inhibiting Zika Virus After Pre-Clinical Study
12 Dezember 2017
Therma Bright Inc.
The Jenex Corporation Announces Graduation to the TSX Venture, Update on Chinese Global Financial Forum and Proposed Acquisition
4 Dezember 2017
Therma Bright Inc.
The Jenex Corporation Announces Completion of Debt Settlement, Files TherOZap(TM) Device Patent and Presents at Chinese Global Financial Forum
23 November 2017
Therma Bright Inc.
The Jenex Corporation Announces AGM Results and Submits Application to Graduate to TSXV
2 November 2017
Therma Bright Inc.
The Jenex Corporation Signs Letter of Intent to Acquire Medical Device Assets
12 Oktober 2017
Therma Bright Inc.
The Jenex Corporation Reports Promising Initial Results on Zika Virus Testing with TherOZap(TM)
19 September 2017
Therma Bright Inc.
The Jenex Corporation Announces Approvals of Equity Financing & Move to TSX Venture Exchange (TSXV)
14 September 2017
Therma Bright Inc.
Jenex Reports Expected Date of Test Results for TherOZap(TM) at Inactivating the Zika Virus
17 August 2017
Therma Bright Inc.
The Jenex Corporation Announces Conditional Acceptance of Reactivation from NEX to TSX Venture Exchange, TherOZap(TM) Testing and ISO 13485:2003 Update
21 Juni 2017
Therma Bright Inc.
The Jenex Corporation Completes $317,500 Oversubscribed Non-Brokered Private Placement with Insider Participation
23 Mai 2017
Therma Bright Inc.
Jenex Finalizing Protocol to Test TherOZap(TM) Against the Zika Virus with University Health Network
18 April 2017
Therma Bright Inc.
Jenex to Test TherOZap(TM) Working Prototype and Topical Cannabidiol Oil Against the Zika and West Nile Viruses
7 April 2017
Therma Bright Inc.
Jenex Completes Design of TherOZap(TM) Working Prototype and Signs Service Agreement with University Heath Network to initiate testing against the Zika and West Nile Viruses
6 März 2017
Therma Bright Inc.
Jenex Provides Update on TherOZap(TM) Working Prototype, and InterceptCS
8 Dezember 2016
Therma Bright Inc.
Jenex to Test Next Generation Technology, TherOZap(TM) Against the Zika Virus and West Nile Virus